Alcon

Medtronic exists to solve the world's most challenging health problems through bold innovation and advanced technology. For over 75 years, the company has pioneered groundbreaking health tech that transforms lives, treating more than 70 conditions across the human body - from heart failure to Parkinson's disease. As a global leader in healthcare technology, Medtronic leverages data, AI, and cutting-edge therapies to address complex healthcare challenges that affect millions of people worldwide. With 95,000 employees across 150 countries, the company's mission-driven approach combines medical expertise with technological innovation to restore health, extend life, and alleviate pain for patients everywhere. From its humble beginnings in a Minneapolis garage to becoming the world's largest medical technology company, Medtronic continues to push boundaries and redefine what's possible in healthcare, making a meaningful impact on global health outcomes every day through innovations that put more life into patients' years.

CorDx is a multinational diagnostics company that develops, manufactures, and supplies rapid diagnostic tests and point-of-care medical device solutions. Its product portfolio spans infectious disease detection, pregnancy testing, drug screening, and biomarker detection. Proprietary diagnostics across the range hold CE Marks and approvals from regulatory bodies including the FDA. The company operates a vertically integrated supply chain and maintains manufacturing facilities in the United States as well as internationally. With over 2,100 employees worldwide, CorDx operates across more than 100 countries and, through its broader CorDx Union network, reaches healthcare providers, families, and over a billion users in 170+ countries. The company partners with organizations globally to develop and distribute its diagnostic products at scale. CorDx applies artificial intelligence and data science alongside conventional R&D to its diagnostics work. The company's technical domains include biotechnology, point-of-care device engineering, supply chain management, and manufacturing - areas that call for structured, process-oriented thinking alongside scientific and engineering expertise.

At Agenus, we're driven by a singular, unwavering mission: to end the suffering of cancer patients. For over 30 years, our team of scientists, researchers, and professionals has been united by this purpose, working collaboratively across the US and Europe to discover, develop, and manufacture breakthrough immuno-oncology therapies. Our research and innovation engine has built a comprehensive pipeline of novel immunotherapies that empower the body to recognize and eliminate disease. We believe that the key to transforming cancer treatment lies in harnessing the full power of the immune system - activating it to do what it was meant to do. Our culture is defined by scientific excellence, relentless innovation, and an unwavering focus on patients. We thrive on tackling the toughest challenges in oncology, particularly in areas where current therapies fall short - cold tumors and late-stage cancers that have resisted traditional treatments. The people who thrive here are those who share our passion for making a meaningful difference, who embrace collaboration across disciplines, and who are motivated by the potential to deliver curative therapies to patients who need them most. Every day, we're pushing the boundaries of what's possible in immunotherapy, united by our vision of a future where more patients live longer, fuller lives.

Syneos Health is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. With 29,000 employees across 110 countries, we translate unique clinical, medical affairs and commercial insights into outcomes that address modern market realities. Our unique integrated model combines clinical development, medical affairs, and commercial expertise to support biopharmaceutical companies from early-phase development through product launch and beyond. We have demonstrated exceptional impact in the industry, having helped develop or commercialize 96% of novel oncology drugs approved by the FDA and 93% of oncology products granted marketing authorization by the EMA in recent five-year periods. Whether supporting customers through a Functional Service Provider partnership or a Full-Service environment, our passionate problem solvers collaborate to innovate and accelerate the delivery of therapies to patients worldwide.

In 1999, two science-based companies with shared visions came together to form AstraZeneca: Sweden's Astra AB and the UK's Zeneca Group PLC. This strategic merger combined decades of pharmaceutical expertise, creating a global powerhouse uniquely positioned to push the boundaries of scientific discovery. What began as a union of strengths has evolved into a relentless pursuit of breakthrough therapies, with the company investing billions annually in research and development to transform patient outcomes across oncology, biopharmaceuticals, respiratory, and rare diseases. Today, AstraZeneca stands at the forefront of precision medicine and next-generation therapeutics, harnessing the power of data science, AI, and innovative technologies like cell therapies. With 197 projects in the pipeline and 16 blockbuster medicines, the company operates from six strategic R&D centres spanning Cambridge, Gothenburg, Gaithersburg, Boston, Shanghai, and Beijing. Their bold aspiration to deliver 20 new medicines by 2030 reflects an unwavering commitment to following the science and putting patients first - values that have driven every decision since that pivotal merger more than two decades ago.

Thermo Fisher Scientific is the world leader in serving science, enabling customers to make the world healthier, cleaner and safer. The company delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through its industry-leading brands. With a global team of more than 120,000 colleagues, Thermo Fisher serves customers across pharmaceutical and biotechnology companies, hospitals and clinical diagnostic labs, universities, research institutions, government agencies and industrial organizations. The company's portfolio includes leading brands such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. Thermo Fisher provides comprehensive solutions through its analytical instruments, laboratory equipment, software, services, consumables and reagents. The company's integrated offerings span from research and discovery to diagnosis and cure, accelerating innovation and driving advancements in life sciences, healthcare and industrial markets.